Shares of Madrigal Pharmaceuticals more than tripled in value Monday after the Pennsylvania-based drugmaker said its experimental treatment for a common liver disease succeeded in a closely watched clinical trial.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,